These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2393320)

  • 1. Daily stress and recurrence of genital herpes simplex.
    Rand KH; Hoon EF; Massey JK; Johnson JH
    Arch Intern Med; 1990 Sep; 150(9):1889-93. PubMed ID: 2393320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological and psychosexual implications of herpes simplex virus infections.
    Mindel A
    Scand J Infect Dis Suppl; 1996; 100():27-32. PubMed ID: 9163020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are reported stress and coping style associated with frequent recurrence of genital herpes?
    Cassidy L; Meadows J; Catalán J; Barton S
    Genitourin Med; 1997 Aug; 73(4):263-6. PubMed ID: 9389946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of herpes simplex virus from the genital tract during symptomatic recurrence on the buttocks.
    Kerkering K; Gardella C; Selke S; Krantz E; Corey L; Wald A
    Obstet Gynecol; 2006 Oct; 108(4):947-52. PubMed ID: 17012458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects.
    de Bruyn G; Vargas-Cortez M; Warren T; Tyring SK; Fife KH; Lalezari J; Brady RC; Shahmanesh M; Kinghorn G; Beutner KR; Patel R; Drehobl MA; Horner P; Kurtz TO; McDermott S; Wald A; Corey L
    Vaccine; 2006 Feb; 24(7):914-20. PubMed ID: 16213066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing recurrences of genital herpes--a role for suppressive antiviral therapy.
    Remington M
    JAAPA; 2004 Aug; 17(8):19-24. PubMed ID: 15357167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does chronic stress lead to increased rates of recurrences of genital herpes--a review of the psychoneuroimmunological evidence?
    Goldmeier D; Garvey L; Barton S
    Int J STD AIDS; 2008 Jun; 19(6):359-62. PubMed ID: 18595870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
    Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and reactivation of nongenital lesions among patients with genital herpes simplex virus.
    Benedetti JK; Zeh J; Selke S; Corey L
    Am J Med; 1995 Mar; 98(3):237-42. PubMed ID: 7872339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does psychosocial stress predict symptomatic herpes simplex virus recurrence? A meta-analytic investigation on prospective studies.
    Chida Y; Mao X
    Brain Behav Immun; 2009 Oct; 23(7):917-25. PubMed ID: 19409481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The temporal relationship of psychosocial stress to cellular immunity and herpes labialis recurrences.
    Schmidt DD; Schmidt PM; Crabtree BF; Hyun J; Anderson P; Smith C
    Fam Med; 1991; 23(8):594-9. PubMed ID: 1794671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes.
    Nieuwenhuis RF; van Doornum GJ; Mulder PG; Neumann HA; van der Meijden WI
    Acta Derm Venereol; 2006; 86(2):129-34. PubMed ID: 16648915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital shedding of herpes simplex virus among men.
    Wald A; Zeh J; Selke S; Warren T; Ashley R; Corey L
    J Infect Dis; 2002 Oct; 186 Suppl 1():S34-9. PubMed ID: 12353185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors.
    Krone MR; Wald A; Tabet SR; Paradise M; Corey L; Celum CL
    Clin Infect Dis; 2000 Feb; 30(2):261-7. PubMed ID: 10671325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of herpes simplex virus type 2 transmission with antiviral therapy.
    Corey L; Ashley R;
    Herpes; 2004 Aug; 11 Suppl 3():170A-174A. PubMed ID: 15319087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of 375 patients with genital herpes simplex infections seen between 1973 and 1980.
    Bierman SM
    Cutis; 1983 May; 31(5):548-52, 557, 560-5. PubMed ID: 6851653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
    Leone P
    Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.